Randomized placebo-controlled adjunctive study of an extract of withania somnifera for cognitive dysfunction in bipolar disorder

The Journal of Clinical Psychiatry
K N Roy ChengappaRipu Jindal

Abstract

Cognitive impairments contribute significantly to inadequate functional recovery following illness episodes in bipolar disorder, yet data on treatment interventions are sparse. We assessed the cognitive effects of a standardized extract of the medicinal herb Withania somnifera (WSE) in bipolar disorder. Sixty euthymic subjects with DSM-IV bipolar disorder were enrolled in an 8-week, double-blind, placebo-controlled, randomized study of WSE (500 mg/d) as a procognitive agent added adjunctively to the medications being used as maintenance treatment for bipolar disorder. Study enrollment and data analyses were completed between December 2008 and September 2012. Cognitive testing at baseline and 8 weeks assessed primary efficacy outcomes. Psychopathology and adverse events were monitored at scheduled visits. Fifty-three patients completed the study (WSE, n = 24; placebo, n = 29), and the 2 groups were matched in terms of demographic, illness, and treatment characteristics. Compared to placebo, WSE provided significant benefits for 3 cognitive tasks: digit span backward (P = .035), Flanker neutral response time (P = .033), and the social cognition response rating of the Penn Emotional Acuity Test (P = .045). The size of the WSE trea...Continue Reading

Associated Clinical Trials

Sep 29, 2008·K.N. Roy Chengappa, K.N. Roy Chengappa
Sep 17, 2019·Stacy D'Andre, MD

Citations

Nov 11, 2014·American Journal of Therapeutics·Marsal SanchesJair C Soares
Mar 23, 2015·Phytochemistry·Jonathan GorelickNirit Bernstein
Jan 28, 2015·Journal of Ayurveda and Integrative Medicine·Jessica M GannonK N Roy Chengappa
Sep 7, 2016·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Kamilla W MiskowiakLars V Kessing
Jun 21, 2014·The Australian and New Zealand Journal of Psychiatry·Ji Hyun BaekGustavo Kinrys
May 13, 2017·The International Journal of Neuropsychopharmacology·Brisa SoléEduard Vieta
Nov 24, 2017·Phytotherapy Research : PTR·Karen SavageJerome Sarris
Mar 20, 2019·Expert Review of Neurotherapeutics·Rohit SharmaP K Prajapati
Mar 27, 2018·Phytotherapy Research : PTR·Jerome Sarris
Jun 5, 2018·Evidence-based Complementary and Alternative Medicine : ECAM·Akhlaq A FarooquiWei-Yi Ong
Feb 13, 2020·Focus : Journal of Life Long Learning in Psychiatry·Joseph F Goldberg
Mar 10, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Nur Shafika Mohd Sairazi, K N S Sirajudeen
Apr 3, 2020·Journal of Ethnopharmacology·Nawab John Dar, MuzamilAhmad
Apr 20, 2020·Journal of Ethnopharmacology·Sultan ZahiruddinSayeed Ahmad
Apr 9, 2021·Journal of Ethnopharmacology·Vinod Kumar Joshi, Apurva Joshi
Apr 22, 2021·Degenerative Neurological and Neuromuscular Disease·Nafaa AlzobaidiMaaz Naqvi
May 1, 2021·Biomolecules·Julie GregoryRammohan V Rao
Jul 11, 2021·Neurochemistry International·Ashish KumarRenu Wadhwa
Aug 4, 2020·Mini Reviews in Medicinal Chemistry·Zeba Firdaus, Tryambak Deo Singh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.